Motif Biosciences Raises $1M Series C Financing for Diabetes, Asthma Research | GenomeWeb
NEW YORK (GenomeWeb News) — Motif Biosciences has raised $1 million in series C financing to help pay for research into type 2 diabetes and asthma, partner company Amphion Innovations said today.
 
Amphion, which owns 47 percent of Motif, said it was responsible for $400,000 of the financing round.
 
in March, Motif reported receiving $1.8 million in financing, of which $500,000 came from Amphion.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.